(Q33249461)

English

Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maria Gabriella Ferrandina

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Giovanni Scambia

6

object named as

Giovanni Scambia

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Enrica Martinelli

3

object named as

Enrica Martinelli

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

4

object named as

Amelia Paglia

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Franco O Ranelletti

2

object named as

Franco O Ranelletti

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Gian Franco Zannoni

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

0 references

publication date

11 July 2006

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

182

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

copyright license

Creative Commons Attribution 2.0 Generic

11 July 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

The cyclooxygenases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Regulation of cyclooxygenase-2 pathway by HER2 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Microtubules and actin filaments: dynamic targets for cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Cancer statistics, 1998.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

The role of DNA mismatch repair in platinum drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

21 June 2018

Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: potentiation by Cox-2 inhibition

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1534059

31 October 2018

Cell cycle regulation of the double stranded RNA activated protein kinase, PKR

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-182

21 January 2018

p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16831230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/16831230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of cyclooxygenase‐2 expression on tumor vascularity in advanced stage ovarian serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16831230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 inhibitor and cisplatin combination as a radiosensitizer in the treatment of head and neck cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16831230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16831230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16831230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16831230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16831230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-6-182

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831230%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33249461&oldid=2195168439"